All news

Putin, Modi discuss Sputnik V production in India

The agenda included the development of partnership between the two countries

MOSCOW, April 28. /TASS/. Russian President Vladimir Putin and Indian Prime Minister Narendra Modi have discussed over the phone the development of partnership between the two countries, including the schedule of contacts at different levels, the Kremlin press service reported on Wednesday.

"Issues related to further development of relations of special and privileged strategic partnership between the two countries, including the schedule of contacts at different levels, were discussed," the report said.

They also focused on registration of Russia’s Sputnik V vaccine in India and its following production, the Kremlin said in a statement.

"The leaders welcomed the registration of the Russian vaccine Sputnik V in India and noted its high efficacy and safety. They expressed satisfaction that via the Russian Direct Investment Fund (RDIF) an agreement was reached with Indian companies on production of up to 850 million doses of Sputnik V. Its production is scheduled to begin in May," the statement says.

On Monday, RDIF CEO Kirill Dmitriev said that India would receive the first shipment of Sputnik V COVID-19 vaccine on May 1.

On April 12, India’s Drug Controller General (DCGI) approved the use of Sputnik V. The Russian preparation became the third vaccine authorized in the country. Currently, two vaccines - Covishield developed by the British-Swedish company AstraZeneca and Oxford University and Covaxin of the Indian company Bharat Biotech - are administered in the country.

In accordance with the 2000 Declaration on Strategic Partnership, the Russian and Indian leaders meet annually. However, in 2020, the summit was not held because of the pandemic. Putin was invited to visit India in 2021, but whether the visit will take place will depend on the epidemiological situation, Kremlin Spokesman Dmitry Peskov said earlier.